Agios Pharmaceuticals (AGIO) Insider Trading & Ownership $42.47 -1.96 (-4.41%) (As of 10/1/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Agios Pharmaceuticals (NASDAQ:AGIO) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage4.93%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)8Amount OfInsider Selling(Last 12 Months)$2.11 M AGIO Insider Buying and Selling by Quarter Ad InvestorPlaceSeven “Forever Stocks” could enrich shareholders for decades A few weeks ago, I asked my research team to investigate the top 10 best-performing stocks of the last 30 years. And the results will shock you!Seven Stocks to buy and Hold Forever Agios Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails9/26/2024Cecilia JonesCFOSell2,542$49.03$124,634.26 8/8/2024Brian GoffCEOSell11,091$42.75$474,140.25 4/10/2024Jacqualyn A FouseDirectorSell7,791$27.55$214,642.05 3/5/2024Brian GoffCEOSell4,156$32.57$135,360.92 3/5/2024James William BurnsInsiderSell2,642$32.57$86,049.94 3/5/2024Kaye I Foster-CheekDirectorSell300$32.21$9,663.00 [Urgent!] Web3 Could Send One Crypto Soaring (Ad)Venture Capital corporations and blockchain funds are pouring money into Web3 gaming. And there's one little-known crypto coin that's poised for RAPID growth as we see Web3 expand over the next few years.Click here to review my research and unique strategy to score potential profits from this under-the-2/20/2024Theodore James Jr. WashburnInsiderSell504$26.63$13,421.52 2/14/2024Sarah GheuensInsiderSell642$25.14$16,139.88 1/24/2024Brian GoffCEOSell7,635$21.64$165,221.40 1/24/2024Cecilia JonesCFOSell1,886$21.64$40,813.04 1/24/2024Jacqualyn A FouseDirectorSell10,722$21.64$232,024.08 1/24/2024James William BurnsInsiderSell1,708$21.64$36,961.12 1/24/2024Josh GottheimerU.S. Congress Member (D-NJ)Buy$21.51$1,001 - $15,0001/9/2024Brian GoffCEOSell12,066$22.99$277,397.34 1/9/2024Jacqualyn A FouseDirectorSell8,391$22.99$192,909.09 1/9/2024James William BurnsInsiderSell1,163$22.99$26,737.37 1/5/2024Tsveta MilanovaInsiderSell2,902$22.32$64,772.64 (Data available from 1/1/2013 forward) AGIO Insider Trading Activity - Frequently Asked Questions Who is on Agios Pharmaceuticals's Insider Roster? The list of insiders at Agios Pharmaceuticals includes Brian Goff, Cecilia Jones, David P Schenkein, Jacqualyn A Fouse, James William Burns, Kaye I Foster-Cheek, Sarah Gheuens, Theodore James Jr. Washburn, and Tsveta Milanova. Learn more on insiders at AGIO. What percentage of Agios Pharmaceuticals stock is owned by insiders? 4.93% of Agios Pharmaceuticals stock is owned by insiders. Learn more on AGIO's insider holdings. Which Agios Pharmaceuticals insiders have been selling company stock? The following insiders have sold AGIO shares in the last 24 months: Brian Goff ($1,376,813.55), Cecilia Jones ($264,755.63), David P Schenkein ($3,002,694.55), Jacqualyn A Fouse ($943,537.70), James William Burns ($366,219.55), Kaye I Foster-Cheek ($658,663.00), Sarah Gheuens ($16,139.88), Theodore James Jr. Washburn ($138,443.95), and Tsveta Milanova ($64,772.64). How much insider selling is happening at Agios Pharmaceuticals? Insiders have sold a total of 256,436 Agios Pharmaceuticals shares in the last 24 months for a total of $6,832,040.45 sold. Which members of congress are trading Agios Pharmaceuticals? Josh Gottheimer (D-NJ) has bought shares of Agios Pharmaceuticals in the last year totaling $8,000. Agios Pharmaceuticals Key ExecutivesMr. Brian M. Goff M.B.A. (Age 55)CEO & Director Compensation: $1.23MMs. Cecilia Jones (Age 49)Chief Financial Officer Compensation: $403.36k1 recent tradesMr. James William Burns (Age 46)Corporate Secretary & Chief Legal Officer Compensation: $660.33kDr. Sarah Gheuens M.D. (Age 44)Ph.D., Chief Medical Officer and Head of Research & Development Compensation: $769.2kDr. Lewis Clayton Cantley Ph.D. (Age 75)Co-Founder & Member of Scientific Advisory Board Compensation: $50kDr. Tak Wah Mak D.Sc. (Age 78)FRSC, Ph.D., Co-Founder & Member of Scientific Advisory Board Dr. Craig B. Thompson M.D. (Age 71)Co-Founder & Chairman of Scientific Advisory Board Dr. Shin-San Su Ph.D. (Age 68)Co-Founder & Member of Scientific Advisory Board Mr. T. J. Washburn Jr. (Age 43)Principal Accounting Officer Dr. Clive Patience Ph.D. (Age 60)Chief Technical Operations Officer More Insider Trading Tools from MarketBeat Related Companies: JAZZ Insider Transactions ROIV Insider Transactions ITCI Insider Transactions LNTH Insider Transactions RVMD Insider Transactions ELAN Insider Transactions VKTX Insider Transactions NUVL Insider Transactions CYTK Insider Transactions BPMC Insider Transactions Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: This Is the Top Large-Cap Stock Insiders Are BuyingMatador Resources Insiders Keep Buying Its Stock, Should You?Top 3 Small-Cap Stocks Insiders Are Buying Right Now3 Small Cap Stocks That Insiders Are BuyingMGM Insiders Bet Big on Its Undervalued Stock This page (NASDAQ:AGIO) was last updated on 10/2/2024 by MarketBeat.com Staff From Our PartnersWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | Sponsored320 hedge funds just sold this stock320 hedge funds just sold this stock A strange force has seized control of Wall Street. Hedge funds are alr...Chaikin Analytics | SponsoredThey laughed when he picked Nvidia in 2016…Everyone’s talking about AI right now, but I’ve been talking about it for years. And now I’ve just released...Brownstone Research | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredCentral Bank Abandons USDBillionaire investors are pouring capital into gold at rates never seen before… But what these wealthy "fat...True Gold Republic | SponsoredWho are Nvidia’s New Silent Partners?Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.Weiss Ratings | SponsoredMan who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist My Default Watchlist Adding Agios Pharmaceuticals, Inc. You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Please log in to your account or sign up in order to add this asset to your watchlist. Share Agios Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
